Min, J., Liu, L., Ma, N., Fu, J., Deng, L., Yang, X., Zhang, F., Kang, Y., Liao, C., Zhao, Y., Song, Y., Su, H. (2026). Liposomal irinotecan plus cisplatin/carboplatin as second-line therapy for platinum-sensitive relapsed extensive-stage small cell lung cancer: Interim results of a phase II trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e20128